Dry eye
Conditions
Interventions
Mucosta
Soft Santear
Sponsors
Hiroshima University
Tsukazaki Hospital
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Patients with POAG who are treated concomittantly with Travatanz 0.004% and Cosopt. Patients who met the criteria for Definition and Diagnosis of Dry Eye 2006 in Japan.
Exclusion criteria
Exclusion criteria: (a)Patients with intraocular pressure greater than the target(Refer to the third edition of glaucoma clinical practice guidelines). (b)Patients with anterior eye disease(including blepharitis, lagophthalmos, blepharospasm and iritis) other than dry eye.(Except for history) (c)Patients who had ocular administration of treatment for corneal-conjunctival epithelial disorder or dry eye within two weeks prior to the initiation of the study. (d)Patients who currently have punctal plugs, have had removal of punctal plug(s) or whose punctal plug(s) fell out within 3 months prior to the initiation of the study, or patients with a history of surgical punctal occlusion. (e)Patients who cannot suspend the use of contact lenses or who expect to use contact lenses. (f)Patients who are pregnant, suspected to be pregnant or patients who are breastfeeding. (g)Patients with hypersensitivity to ingredients of the study drugs and test reagents used in this study. (h)Patients who are judged by the investigator to be inappropriate for the study because of a past or concurrent systemic disease.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Fluorescein cornea staining score | — |
Countries
Japan
Outcome results
None listed